CLINICAL_TRIALS
trial_result
· 2022-07-26
Clinical Trial Update: Study of Pegloticase in Participants With Uncontrolled Gout Who Have Had a Kidney Transplant [Phase 4]
Summary
This Phase 4 trial evaluated pegloticase in adults with uncontrolled gout who have had a kidney transplant; results were posted in July 2022.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Amgen | Conditions: Uncontrolled Gout, Kidney Transplant | Phase 4 | Status: COMPLETED | Results posted: 2022-07-26